1. Prognostic value of CAPZA1 overexpression in gastric cancer
- Author
-
Jiyun Yoo, Young-Tae Ju, Chang-Won Lee, Sang-Kyung Choi, Soon-Tae Park, Young-Joon Lee, Sang-Ho Jeong, Gyung Hyuck Ko, Woo-Song Ha, Chi-Young Jeong, Bok-Im Cho, Soon-Chan Hong, Eun-Jung Jung, and Jae Won Kim
- Subjects
Male ,Oncology ,Cancer Research ,medicine.medical_specialty ,Biology ,Malignancy ,Cell Movement ,Stomach Neoplasms ,Internal medicine ,medicine ,Humans ,Neoplasm Invasiveness ,Stage (cooking) ,F-actin capping protein ,Lymph node ,Aged ,CapZ Actin Capping Protein ,Univariate analysis ,Oncogene ,CAPZA1 ,Cancer ,Articles ,Middle Aged ,Cell cycle ,Prognosis ,medicine.disease ,Gene Expression Regulation, Neoplastic ,medicine.anatomical_structure ,Lymphatic Metastasis ,stomach neoplasm ,immunohistochemistry ,biomarker ,Lymph Node Excision ,Female ,Lymph ,Neoplasm Recurrence, Local - Abstract
F-actin capping protein α1 subunit (CAPZA1) was previously identified in a proteomic analysis of human gastric cancer clinical specimens and selected for further study. The association between CAPZA1 overexpression, detected by immunohistochemistry, and clinicopathological features including survival were evaluated. In vitro gain-of-function and loss-of-function approaches were utilized to assess the function of CPAZA1 in malignancy. Univariate analysis revealed that poorly differentiated disease, according to the World Health Organization (WHO) classification, advanced T stage, positive lymph nodes, high TNM stage, D2 lymph node dissection, adjuvant chemotherapy and CAPZA1 underexpression were significantly associated with cancer-related death (p
- Published
- 2013
- Full Text
- View/download PDF